Sign in
CompletedNo phase

Screening Instruments for Measuring Visual Symptoms in Victims of Concussion

Key facts

Who runs it
Bispebjerg Hospital
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
197 people enrolled
Started
1 Dec 2022
Ended
31 Oct 2024
Type of study
Observational, 2 groups
Record updated
9 September 2026

Who can take part

Age
18 years to 67 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Individuals may be included if they:
  • are adults between the ages 18 and 67
  • have been diagnosed with mTBI by a doctor (emergency room or general practice) either exclusively or with another diagnosis e.g. fracture, neck trauma (doesn't apply to control group)
  • can read and understand Danish
  • continuously have symptoms related to trauma ≥ 2 months and ≤ 24 months after trauma origin (doesn't apply to control group)
  • have best corrected visus at 0.8 or better in both eyes at distance
  • have given informed consent and willingness to participate in the study

Who cannot take part

  • have a verified alcohol or drug abuse
  • have received vision therapy by an optometrist in relation to resent mTBI
  • are diagnosed with one of the following neurological disorders: severe head trauma, brain tumor, Parkinson's disease, multiple sclerosis, dementia
  • are diagnosed with a current active psychiatric disorder
  • are diagnosed with one of the following somatic disorders which are unregulated: diabetes mellitus, metabolic disorders
  • have other visual problems such as constant strabismus, a history of strabismus surgery, congenital nystagmus and recognized eye illnesses such as glaucoma, age-related macular degeneration (AMD)
  • The following will be excluded if individuals:
  • have amblyopia (that is, two lines difference or more in best corrected visus between the two eyes)

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Visual dysfunction after mild traumatic brain injury (mTBI) is common but often remain undiscovered during longer periods of time. No valid, reliable and easy-to-use screening instrument for uncovering visual dysfunction exists. Furthermore, it is unknown whether optometric measurements currently used in assessing vision problems are consistent with patients' subjective complaints experienced in everyday life. A better understanding of patients' visual challenges combined with objective measurements, will contribute to a better and more efficient diagnostic investigation and treatment.

Read full original descriptionShow less

The aim of this study is to get a better understanding of patients who are suffering from visual dysfunction after mTBI. This understanding will be gained by:

1. developing and validating a questionnaire for uncovering subjective visual complaints in subjects with mTBI. 2. developing eye tracking based screening tools applicable both in- and outside of optometry clinics 3. examining relationships between self-reported data, eye tracking measurements and optometric measurements.

The study will consist of N = 200 subjects. N = 100 of the subjects are suffering from mTBI (commotio group). The second group N = 100 is the non-injured group that preferably will consist of relatives to the subjects in the commotio group. The subjects in both groups have to answer the questionnaires regarding subjective visual complains, undergo optometric tests and undergo eye tracking measurements.

The 2 groups in the trial

  • Mild traumatic brain injury group

    Consist of patients who have been diagnosed with mTBI by a doctor at an emergency room or in general practice. The patients must still have symptoms related to their trauma ≥ 2 months and ≤ 24 months after trauma origin. They must not have received any vision therapy from an optometrist in relation to resent mTBI.

  • Non-injured group

    The control group will primarily consist of relatives of the individuals with mTBI, preferably a partner or a sibling. The subjects in the control group have to meet the same inclusion and exclusion criteria as the mTBI group, except that they must not be diagnosed with mild traumatic brain injury.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
9 September 2026